Maternal HIV: Trial to Assist Disclosure to Children
TRACK II
2/2-Maternal HIV: Multisite Trial to Assist Disclosure to Children
2 other identifiers
interventional
362
1 country
1
Brief Summary
The purpose of this Collaborative R01, under Program Announcement PAR-09-153, is to conduct a full-scale trial of an intervention to assist mothers living with HIV (MLH) with disclosing their serostatus to their young age 6 - 14 year old), well children. A pilot study of the intervention has recently been completed (R01 MH077493) and met its major aims. The basis for development of the pilot intervention was work from three R01s (MH057207, currently Yr. 14) designed to longitudinally assess MLH and their children. Within that work, several studies were conducted on maternal disclosure, suggesting disclosure is difficult, and outcomes for MLH and children could be improved by intervention. The pilot study, known in the community as Teaching, Raising, And Communicating with Kids (TRACK), was based on integrative disclosure theory. Results of the pilot trial indicate that those in the intervention group were six times more likely to disclose their HIV/AIDS status to their child than those in the control group (O.R. 6.33); by the 9-month follow-up 33% of intervention MLH disclosed, compared to only 7.3% of the control group. Perhaps more importantly, the intervention group's emotional functioning and their satisfaction improved significantly following the intervention, compared to the control group. Similarly, child mental health indicators among children of intervention MLH were significantly better than control group children at follow-ups. In this study, TRACK II, we propose to conduct a full-scale trial of the intervention in two sites: (1) Los Angeles county (Site 1, where the pilot trial was conducted), which will include a high proportion of Latina families and a smaller proportion of African-American and White families; and (2) Atlanta, Georgia (Site 2, where the primary consultant on the pilot trial conducts research), which will include a high proportion of Southern African-American families, as well as White families. MLH and their children (N = 440 total; 110 mothers and 110 children per site, n = 220 per site) will be assessed at baseline and at 3, 9, and 15-month follow-ups. MLH will be randomly assigned to the intervention or control. Aims are to:
- 1.facilitate disclosure of the mothers' HIV status to the children, which will include secondary aims of:
- 2.increasing mothers' self-efficacy to disclose and respond to child questions regarding HIV;
- 3.reducing mothers' fears regarding disclosure and stigma;
- 4.improving maternal knowledge of child development and how to provide appropriate levels of information given the age of the child;
- 5.improve MLH mental health indicators over time (i.e., depression, anxiety, quality of life);
- 6.improve child mental health indicators over time (i.e., depression, anxiety, acting out behaviors); and
- 7.improve family functioning indicators (e.g., cohesion, perceived closeness between mother and child).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv
Started Mar 2013
Longer than P75 for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 2, 2013
CompletedFirst Posted
Study publicly available on registry
August 14, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedJanuary 18, 2020
January 1, 2020
4.7 years
August 2, 2013
January 14, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Disclosure of Maternal HIV status to child
Change in disclosure status between time points 3-, 9-, & 15 month follow ups
Secondary Outcomes (1)
Child Mental Health Functioning (Composite measure)
15- month follow up
Other Outcomes (2)
Maternal Functioning (composite measure)
15 month follow-up
Family functioning (composite measure)
15 month follow-up
Study Arms (2)
Wait-list Control
NO INTERVENTIONParticipants in the wait-list control condition will receive a group-based version of the TRACK intervention after their 15-month follow up appointment.
TRACK Intervention
EXPERIMENTAL3-session, individually administered psycho-educational intervention to promote maternal disclosure of HIV status to child
Interventions
TRACK Intervention 3-session, individually administered psycho-educational intervention to promote maternal disclosure of HIV status to child
Eligibility Criteria
You may qualify if:
- Mother is HIV+
- ability of mother and child to speak and understand English or Spanish
- child is not HIV+
- Child is 6-14 years old
- Child is unaware of maternal HIV status
- child resides with mother
You may not qualify if:
- Mother does not consent
- Child does not assent
- Psychosis of mother or child
- Child diagnosed with depression
- child is developmentally delayed
- Recent or anticipated death in the family
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Georgia State Universitylead
- University of California, Los Angelescollaborator
- National Institute of Mental Health (NIMH)collaborator
Study Sites (1)
Georgia State University
Atlanta, Georgia, 30302, United States
Related Publications (2)
Marelich WD, Ali B, Murphy DA, Schulte MT, Armistead L. Predictors of serostatus nondisclosure in mothers living with human immunodeficiency virus receiving a disclosure intervention: Analysis of a randomized clinical trial intervention arm. Health Psychol. 2024 Sep;43(9):663-672. doi: 10.1037/hea0001390. Epub 2024 Apr 25.
PMID: 38661649DERIVEDSchulte MT, Armistead L, Murphy DA, Marelich W. Multisite longitudinal efficacy trial of a disclosure intervention (TRACK) for HIV+ mothers. J Consult Clin Psychol. 2021 Feb;89(2):81-95. doi: 10.1037/ccp0000622.
PMID: 33705165DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa P Armistead, Ph.D.
Georgia State University
- PRINCIPAL INVESTIGATOR
Debra Murphy, Ph.D.
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Distinguished Professor
Study Record Dates
First Submitted
August 2, 2013
First Posted
August 14, 2013
Study Start
March 1, 2013
Primary Completion
November 1, 2017
Study Completion
November 1, 2019
Last Updated
January 18, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will share
Data sharing protocols for the longitudinal data from 220 young children and 220 mothers will be in accordance with NIH Notice of Amendment to A-110, consistent with IRB-approved consent restrictions, and follow Inter-University Consortium for Political and Social Research guidelines for data preparation. Data will be stripped of identifiers and available under signed agreement for: (1) using data only for research; (2) securing date using appropriate technology; and (3) destroying or returning data after analyses. Notice of available data will be on both centers' websites, with data use restrictions.